Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,943,570
  • Shares Outstanding, K 133,839
  • Annual Sales, $ 2,519 M
  • Annual Income, $ 102,980 K
  • EBIT $ 490 M
  • EBITDA $ 985 M
  • 60-Month Beta 1.06
  • Price/Sales 4.38
  • Price/Cash Flow 15.18
  • Price/Book 2.82

Options Overview Details

View History
  • Implied Volatility 31.07% (+3.29%)
  • Historical Volatility 23.90%
  • IV Percentile 24%
  • IV Rank 16.68%
  • IV High 61.02% on 11/03/25
  • IV Low 25.08% on 12/08/25
  • Expected Move (DTE 21) 4.31 (4.55%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 185
  • Volume Avg (30-Day) 621
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 10,933
  • Open Int (30-Day) 13,298
  • Expected Range 90.49 to 99.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.86
  • Number of Estimates 5
  • High Estimate 0.97
  • Low Estimate 0.68
  • Prior Year 0.68
  • Growth Rate Est. (year over year) +26.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.01 +10.29%
on 02/05/26
97.87 -3.08%
on 02/26/26
+2.90 (+3.15%)
since 01/27/26
3-Month
84.70 +12.00%
on 12/17/25
101.40 -6.45%
on 01/08/26
+3.78 (+4.15%)
since 11/26/25
52-Week
51.79 +83.16%
on 08/01/25
101.40 -6.45%
on 01/08/26
+16.19 (+20.58%)
since 02/27/25

Most Recent Stories

More News
Globus Medical: Q4 Earnings Snapshot

Globus Medical: Q4 Earnings Snapshot

GMED : 95.12 (-1.64%)
Globus Medical (NYSE:GMED) Delivers Strong Q4 CY2025 Numbers

Globus Medical (NYSE:GMED) Delivers Strong Q4 CY2025 Numbers

GMED : 95.12 (-1.64%)
Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter...

GMED : 95.12 (-1.64%)
Globus Medical (GMED) Reports Earnings Tomorrow: What To Expect

Globus Medical (GMED) Reports Earnings Tomorrow: What To Expect

GMED : 95.12 (-1.64%)
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year...

GMED : 95.12 (-1.64%)
1 Cash-Heavy Stock with Promising Prospects and 2 We Find Risky

1 Cash-Heavy Stock with Promising Prospects and 2 We Find Risky

GMED : 95.12 (-1.64%)
STRA : 82.00 (+4.58%)
MX : 2.75 (-3.51%)
2 Reasons to Watch GMED and 1 to Stay Cautious

2 Reasons to Watch GMED and 1 to Stay Cautious

GMED : 95.12 (-1.64%)
1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm

1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm

GMED : 95.12 (-1.64%)
OKTA : 72.51 (-3.64%)
DOX : 69.69 (-0.24%)
1 Mooning Stock to Keep an Eye On and 2 Facing Challenges

1 Mooning Stock to Keep an Eye On and 2 Facing Challenges

BHF : 59.95 (-0.43%)
GMED : 95.12 (-1.64%)
HTH : 37.43 (-3.58%)
2 Healthcare Stocks to Keep an Eye On and 1 We Ignore

2 Healthcare Stocks to Keep an Eye On and 1 We Ignore

MEDP : 452.10 (+1.12%)
GMED : 95.12 (-1.64%)
PRVA : 23.84 (-4.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices,...

See More

Key Turning Points

3rd Resistance Point 101.14
2nd Resistance Point 99.50
1st Resistance Point 98.11
Last Price 95.12
1st Support Level 95.08
2nd Support Level 93.44
3rd Support Level 92.05

See More

52-Week High 101.40
Last Price 95.12
Fibonacci 61.8% 82.45
Fibonacci 50% 76.59
Fibonacci 38.2% 70.74
52-Week Low 51.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar